|
Chentouf M, Rigo M, Ghannam S, Navarro-Teulon I, Mongrand S, Pèlegrin A, Chardès T. The lipid-modulating effects of a CD4-specific recombinant antibody correlate with ZAP-70 segregation outside membrane rafts. Immunol Lett. 2010 Jul 23. [Epub ahead of print]
Ladjemi MZ, Jacot W, Chardès T, Pèlegrin A, Navarro-Teulon I. Anti-HER2 vaccines: new prospects for breast cancer therapy. Télécharger l'article :  
Santoro L, Boutaleb S, Garambois V, Bascoul-Mollevi C, Boudousq V, Kotzki PO, Pèlegrin M, Navarro-Teulon I, Pèlegrin A, Pouget JP. Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis. J Nucl Med. 2009 Nov 12. [Epub ahead of print]
Larbouret C, Robert B, Bascoul-Mollevi C, Penault-Llorca F, Ho-Pun-Cheung A, Morisseau S, Navarro-Teulon I, Mach JP, Pèlegrin A, Azria D. Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts. Ann Oncol. 2009 Nov 4. [Epub ahead of print]
Stork R, Campigna E, Robert B, Mueller D, Kontermann RE. Biodistribution of a bispecific single-chain diabody and its half-life extended derivatives. J Biol Chem. 2009 Jul 23
Alvarez-Rueda N, Ladjemi MZ, Behar G, Corgnac S, Pugniere M, Roquet F, Bascoul-Mollevi C, Baty D, Pelegrin A, Navarro-Teulon I. A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy. Vaccine 2009. In Press
Faruque OM, Le-Nguyen D, Lajoix AD, Vives E, Petit P, Bataille D, Hani el H. Cell-permeable peptide-based disruption of endogenous PKA-AKAP complexes: a tool for studying the molecular roles of AKAP-mediated PKA subcellular anchoring. Am J Physiol Cell Physiol 2009; 296: C306-316.
Azria D, Ozsahin M, Kramar A, Peters S, Atencio DP, Crompton NE, Mornex F, Pelegrin A, Dubois JB, Mirimanoff RO, Rosenstein BS. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 2008; 14: 6284-6288.Pouget JP, Santoro L, Raymond L, Chouin N, Bardies M, Bascoul-Mollevi C, Huguet H, Azria D, Kotzki PO, Pelegrin M, Vives E, Pelegrin A. Cell Membrane is a More Sensitive Target than Cytoplasm to Dense Ionization Produced by Auger Electrons. Radiat Res 2008; 170: 192-200.
Ychou M, Azria D, Menkarios C, Faurous P, Quenet F, Saint-Aubert B, Rouanet P, Pelegrin M, Bascoul-Mollevi C, Guerreau D, Saccavini JC, Mach JP, Artus JC, Pelegrin A. Adjuvant Radioimmunotherapy Trial with Iodine-131-Labeled Anti-Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab')2 after Resection of Liver Metastases from Colorectal Cancer. Clin Cancer Res 2008; 14: 3487-3493.
Kucharczak J, Charrasse S, Comunale F, Zappulla J, Robert B, Teulon-Navarro I, Pelegrin A, Gauthier-Rouviere C. R-Cadherin expression inhibits myogenesis and induces myoblast transformation via Rac1 GTPase. Cancer Res 2008; 68: 6559-6568.
|
 |
Ho-Pun-Cheung, A., Assenat, E., Thezenas, S., Bibeau, F., Rouanet, P., Azria, D., Cellier, D., Grenier, J., Ychou, M., Senesse, P., and opez-Crapez, E. Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer. Int J Radiat Oncol Biol Phys, 2007.
Omlin, A., Amichetti, M., Azria, D., Cole, B. F., Fourneret, P., Poortmans, P., Naehrig, D., Miller, R. C., Krengli, M., Gutierrez Miguelez, C., Morgan, D., Goldberg, H., Scandolaro, L., Gastelblum, P., Ozsahin, M., Dohr, D., Christie, D., Oppitz, U., Abacioglu, U., and Gruber, G. Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol, 7: 652-656, 2006.
Roncalli, J., Delord, J. P., Galinier, M., Massabuau, P., Lescure, M., Fauvel, J. M., and Azria, D. Bevacizumab in metastatic colorectal cancer: a left intracardiac thrombotic event. Ann Oncol, 17: 1177-1178, 2006.
Toledano, A., Garaud, P., Serin, D., Fourquet, A., Bosset, J. F., Breteau, N., Body, G., Azria, D., Le Floch, O., and Calais, G. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study. Int J Radiat Oncol Biol Phys, 65: 324-332, 2006.
Zimmermann, M., Zouhair, A., Azria, D., and Ozsahin, M. The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. Radiat Oncol, 1: 11, 2006.
Germain C, Larbouret C, Cesson V, Donda A, Held W, Mach JP, Pèlegrin A, Robert B. MHC class-I-related chain A (MICA) conjugated to anti- tumorantibodies can sensitize tumor cells to specific lysis by NK cells. Clin Cancer Res 2005 11: 7516-22..
Azria D, Larbouret C, Cunat S, Ozsahim M, Gourgou S, Martineau P, Evans D, Romieu G, Pujol P, Pèlegrin A. Letrozole sensitizes Breast Cancer Cells to Ionizing Radiation. Breast Cancer Res 2005 7: R156-R163.
Salhi I, Cambon-Roques S, Lamarre I, Laune D, Molina F, Pugniere M, Pourquier D, Gutowski M, Picard JY, Xavier F, Pèlegrin A, Navarro-Teulon I. The anti-Mullerian hormone type II receptor: Insights into the binding domains recognized by a monoclonal antibody and the natural ligand. Biochem J 2004 379: 785-793.
Garambois V, Glaussel F, Foulquier E, Ychou M, Pugniere M, Luo RX, Bezabeh B, Pèlegrin A. Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers. BMC Cancer 2004 4: 75.
Coelho M, Gauthier P, Pugniere M, Roquet F, Pèlegrin A, Navarro-Teulon I. Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice. Brit J Cancer 2004 90: 2032-2041.
|
